Cardiovascular Involvement in Chronic Hepatitis C Virus Infections - Insight from Novel Antiviral Therapies. Poller W, Haghikia A, Kasner M, Kaya Z, Bavendiek U, Wedemeier H, Epple HJ, Skurk C, Landmesser U. J Clin Transl Hepatol. 2018 Jun 28;6(2)…

Occult Hepatitis C Virus Infection: A Review. Austria A, Wu GY. J Clin Transl Hepatol. 2018 Jun 28;6(2):155-160. doi: 10.14218/JCTH.2017.00053. Epub 2018 Feb 14. Review. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6018308/

A qualitative assessment of the acceptability of hepatitis C remote self-testing and self-sampling amongst people who use drugs in London, UK. Guise A, Witzel TC, Mandal S, Sabin C, Rhodes T, Nardone A, Harris M. BMC Infect Dis. 2018 Jun 19;18(1)…

Risk of de novo Hepatocellular Carcinoma after HCV Treatment with Direct-Acting Antivirals. Finkelmeier F, Dultz G, Peiffer KH, Kronenberger B, Krauss F, Zeuzem S, Sarrazin C, Vermehren J, Waidmann O. Liver Cancer. 2018 May;7(2):190-204. doi: 10.1…

The management of chronic hepatitis C: 2018 guideline update from the Canadian Association for the Study of the Liver. Shah H, Bilodeau M, Burak KW, Cooper C, Klein M, Ramji A, Smyth D, Feld JJ; Canadian Association for the Study of the Liver. CMA…

Integrated Hepatitis C Care for People Who Inject Drugs (Heplink): Protocol for a Feasibility Study in Primary Care. McCombe G, Swan D, O'Connor E, Avramovic G, Vickerman P, Ward Z, Surey J, Macías J, Lambert JS, Cullen W. JMIR Res Protoc…